The combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) and Genistein is effective in inhibiting pancreatic cancer growth.

Nozawa F., Itami A., Saruc M., Kim M., Standop J., Picha K., ...Daha Fazla

Pancreas, cilt.29, ss.45-52, 2004 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 29
  • Basım Tarihi: 2004
  • Doi Numarası: 10.1097/00006676-200407000-00055
  • Dergi Adı: Pancreas
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.45-52
  • Anahtar Kelimeler: TRAIL/Apo2L, genistein, apoptosis, pancreatic cancer, TRAIL-INDUCED APOPTOSIS, IN-VIVO, CELL-LINE, FACTOR RECEPTOR, AKT, CHEMOTHERAPY, CARCINOMA, DEATH, OVEREXPRESSION, INDUCTION
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır